<?xml version="1.0" encoding="UTF-8"?><feed xmlns="http://www.w3.org/2005/Atom">
  <title>医药魔方Pro | wechat-feeds</title>
  <id>https://github.com/hellodword/wechat-feeds</id>
  <updated>2020-11-06T17:34:31+08:00</updated>
  <subtitle>聚焦生物医药前沿，洞察研发投资风向</subtitle>
  <link href="https://github.com/hellodword/wechat-feeds"></link>
  <author>
    <name>hellodword</name>
  </author>
  <entry>
    <title>KRAS抑制剂「图鉴」</title>
    <updated>2020-11-05T21:00:19+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-05:/s/BoyUDzPU7O_pyJ-pPhlxlQ</id>
    <link href="https://mp.weixin.qq.com/s/BoyUDzPU7O_pyJ-pPhlxlQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>癌症免疫疗法“下一站”——NK细胞</title>
    <updated>2020-11-04T20:59:22+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-04:/s/75shNj1qeWSKW41GMFM3ZQ</id>
    <link href="https://mp.weixin.qq.com/s/75shNj1qeWSKW41GMFM3ZQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>加强版PI3K抑制剂来了！高效抑制小鼠肺纤维化，提高生存率 | Science子刊</title>
    <updated>2020-11-03T21:02:05+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-03:/s/-HQL5IL8iBmd1d0qcvOuVQ</id>
    <link href="https://mp.weixin.qq.com/s/-HQL5IL8iBmd1d0qcvOuVQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>癌症免疫疗法“新武器”——β-葡聚糖 | Cell突破成果</title>
    <updated>2020-11-02T21:28:37+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-02:/s/8B9RYB011Yrg3IkTKlZeng</id>
    <link href="https://mp.weixin.qq.com/s/8B9RYB011Yrg3IkTKlZeng" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>医药魔方Pro，等你加入！</title>
    <updated>2020-11-01T21:05:51+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-01:/s/no2ug0iZdsTosS2BFSRUbg</id>
    <link href="https://mp.weixin.qq.com/s/no2ug0iZdsTosS2BFSRUbg" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>I期数据积极！双特异性CAR-T疗法：高效抗肿瘤，ORR达82% | Nature子刊</title>
    <updated>2020-10-31T21:00:31+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-10-31:/s/a0BbOLy4j1QFMSoX5hWjsA</id>
    <link href="https://mp.weixin.qq.com/s/a0BbOLy4j1QFMSoX5hWjsA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>2020Q3 | 制药巨头新疗法「消费图鉴」</title>
    <updated>2020-10-30T21:01:17+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-10-30:/s/w5NzPNlcZx7kWi37T86B5Q</id>
    <link href="https://mp.weixin.qq.com/s/w5NzPNlcZx7kWi37T86B5Q" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>基因疗法赛道持续升温：巨资入场，未来可期</title>
    <updated>2020-10-29T21:14:57+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-10-29:/s/8-lP-pgzw_P0kHcKVgJadQ</id>
    <link href="https://mp.weixin.qq.com/s/8-lP-pgzw_P0kHcKVgJadQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>聚焦PROTAC：2001-2019年靶点汇总</title>
    <updated>2020-10-28T20:59:10+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-10-28:/s/qu6euyzeNb7DBtKtWdqdOg</id>
    <link href="https://mp.weixin.qq.com/s/qu6euyzeNb7DBtKtWdqdOg" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>PARP抑制剂“新搭档”——USP1抑制剂</title>
    <updated>2020-10-27T20:59:21+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-10-27:/s/PqyUnGHz-cLy574G9mNu-Q</id>
    <link href="https://mp.weixin.qq.com/s/PqyUnGHz-cLy574G9mNu-Q" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
</feed>